Latest News about ALLO
Recent news which mentions ALLO
Earnings Scheduled For August 13, 2025
August 13, 2025
From Benzinga
A Look at Allogene Therapeutics's Upcoming Earnings Report
August 12, 2025
Tickers
ALLO
From Benzinga
This AvalonBay Communities Analyst Is No Longer Bullish; Here Are Top 4 Downgrades For Monday
August 04, 2025
From Benzinga
From Benzinga
From Benzinga
Earnings Scheduled For May 13, 2025
May 13, 2025
From Benzinga
Earnings Scheduled For March 13, 2025
March 13, 2025
From Benzinga
Watsco Posts Upbeat Results, Joins GeneDx, Intel And Other Big Stocks Moving Higher On Tuesday
February 18, 2025
From Benzinga
7 Biotech Stocks to Buy for Their Game-Changing Potential
August 08, 2024
From InvestorPlace
Cell Therapy Mostly Used For Blood Cancer Shows Efficacy In Autoimmune Diseases As Well, But There Are Challenges
July 19, 2024
From Benzinga
From InvestorPlace
From Benzinga
Why Larimar Therapeutics Shares Are Trading Higher By 18%; Here Are 20 Stocks Moving Premarket
May 21, 2024
From Benzinga
Why Arcutis Biotherapeutics Shares Are Trading Higher By 29%; Here Are 20 Stocks Moving Premarket
May 15, 2024
From Benzinga
DLocal, Allogene Therapeutics And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
May 15, 2024
From Benzinga
Tickers
ALLO
From InvestorPlace
From Benzinga
To The Moon! A Look Inside An ETF Focused On Companies At The Cutting Edge Of Innovation
April 18, 2024
From Benzinga
3 Meme Stocks to Sell and Replace With Meme Coins
April 11, 2024
From InvestorPlace
Tickers
ALLO
From InvestorPlace
Earnings Scheduled For March 14, 2024
March 14, 2024
From Benzinga
CymaBay Therapeutics, ContextLogic, Snap And Other Big Stocks Moving Higher On Monday
February 12, 2024
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.